Skip to main content
. 2021 Sep 7;28(7-8):779–790. doi: 10.3727/096504021X16161478258040

Figure 9.

Figure 9

Effect of BX795 on cell viability in primary glioblastoma multiforme (GBM) cell culture. Cell viability was evaluated using MTT assay 24 h after BX795 treatment at the concentration of 10 μM. The result demonstrated that 10 μM BX795 treatment reduced cell viability in primary GBM cells (A). Cell proliferation was evaluated at T0, 24, 48, and 72 h in primary GBM cell. BX795 treatment 10 μM was able to suppress cell proliferation compared to the control group (B). Data are representative of at least three independent experiments. ##p < 0.01 versus GBM.